Clinical Trial Detail

NCT ID NCT02138617
Title Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Leucovorin

Bevacizumab

Irinotecan

Fluorouracil

Age Groups: adult

No variant requirements are available.